Nemzetközi hírek
Issued: Wednesday 25 July 2018 London UK and Mountain View, CA
Multi-year collaboration expected to identify novel drug targets, tackle new subsets of disease and enable rapid progression of clinical programmes
- The Sir Andrew Witty GSK Scholarships will be funded by GSK and run by the London School of Hygiene & Tropical Medicine
- 10-year agreement to fund 30 scholars from sub-Saharan Africa on a Master of Science programme
GSK announces that Emma Walmsley, currently Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division, is appointed GSK CEO Designate and will succeed Andrew Witty as GSK CEO, when he retires on 31 March 2017. Emma will join the GSK Board of Directors from 1 January 2017.
Tovább - Emma Walmsley to succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline Tovább